|
LIN9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.940240E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.176800E-03 |
| Normal-vs-Stage2 |
4.319200E-03 |
| Normal-vs-Stage3 |
1.910350E-01 |
| Normal-vs-Stage4 |
1.34939999951733E-07 |
| Stage1-vs-Stage2 |
3.836000E-01 |
| Stage1-vs-Stage3 |
9.243400E-01 |
| Stage1-vs-Stage4 |
1.362480E-04 |
| Stage2-vs-Stage3 |
7.576400E-01 |
| Stage2-vs-Stage4 |
1.667960E-02 |
| Stage3-vs-Stage4 |
1.061020E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.411800E-04 |
| Normal-vs-AfricanAmerican |
1.712210E-01 |
| Normal-vs-Asian |
7.084500E-03 |
| Caucasian-vs-AfricanAmerican |
5.005600E-01 |
| Caucasian-vs-Asian |
5.456200E-01 |
| AfricanAmerican-vs-Asian |
8.112400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.754600E-01 |
| Normal-vs-Female |
6.352300E-04 |
| Male-vs-Female |
3.818400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.922500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.354400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.606200E-04 |
| Normal-vs-Age(81-100Yrs) |
4.031700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.054200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.821380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.096200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.690000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.119200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.489400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.336600E-03 |
| Classical-VS-Follicular |
1.499440E-01 |
| Classical-VS-Other |
9.486400E-01 |
| Classical-VS-Normal |
1.336650E-03 |
| Tall-VS-Follicular |
1.107590E-02 |
| Tall-VS-Other |
1.810240E-01 |
| Tall-VS-Normal |
4.19519999994566E-06 |
| Follicular-VS-Other |
3.986000E-01 |
| Follicular-VS-Normal |
9.747000E-01 |
| Other-VS-Normal |
2.081200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.633170E-01 |
| Normal-vs-N1 |
1.15239999998185E-06 |
| N0-vs-N1 |
4.256500E-03 |
|
|
